UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5300-0.0100 (-0.39%)
As of 02:00PM EST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
68,307
111,997
-172,415
-183,524
-176,145
Depreciation & amortisation
594
1,193
4,093
4,067
1,391
Stock-based compensation
4,140
11,572
18,125
10,679
10,694
Change in working capital
-35,129
-4,086
-520
-3,316
-14,000
Accounts receivable
-
-
-4,327
-8,200
-13,640
Inventory
-
-
-711
-3,337
-8,593
Accounts payable
-1,387
-1,211
-750
1,887
-3,563
Other working capital
-1,396
-4,433
-144,916
-161,068
-189,590
Other non-cash items
156
-394
7,491
10,867
1,919
Net cash provided by operating activities
-1,322
-4,078
-142,693
-159,470
-165,698
Cash flows from investing activities
Investments in property, plant and equipment
-
-355
-2,223
-1,598
-23,892
Other investing activities
-20.42
-
-
-
-20.42
Net cash used for investing activities
223,760
223,479
-2,223
-1,598
-23,913
Cash flows from financing activities
Debt repayment
-94,432
-219,432
-50,000
0
-81,661
Common stock issued
1,163
2,468
184,115
31,703
77,031
Common stock repurchased
-
-38,657
-
-
-
Other financing activities
-
-1,269
-5,118
48,750
-6,652
Net cash used provided by (used for) financing activities
-110,796
-235,206
129,552
80,724
188,827
Net change in cash
-28,164
-15,805
-15,364
-80,344
-783.364
Cash at beginning of period
38,330
65,122
80,486
160,830
161,613
Cash at end of period
10,166
49,317
65,122
80,486
160,830
Free cash flow
Operating cash flow
-1,322
-4,078
-142,693
-159,470
-165,698
Capital expenditure
-
-355
-2,223
-1,598
-23,892
Free cash flow
-1,396
-4,433
-144,916
-161,068
-189,590